Search Site

Trends banner

TikTok’s US future uncertain

It must find non-Chinese owner to avoid ban.

Tesla Q1 sales sink 13 percent

The dip occurred amid lower production during factory upgrades.

AD Ports Group 2024 revenue $4.70bn

The Group's EBITDA increased by 69 percent YOY.

Tesla sales tumble in Europe in Q1

The company suffered from boycotts against the policies of Elon Musk.

Ford’s US Q1 auto sales dip

But its Q1 figures exceed a forecast by Edmunds

ADIA, EQT to buy Dechra  

The announcement sent Dechra's share price soaring eight percent to US$45.6 in early deals on London's rising stock market. (AFP)
  • The offer was pitched at US$48.5 (£38.75) per share - a 44-percent premium from April 12 - before Dechra first revealed it was holding bid talks.
  • Dechra Pharmaceuticals has over 2,000 employees and seven production sites across the world, and sells veterinary products in 63 countries.

LONDON, UK – UK petcare firm Dechra Pharmaceuticals has agreed a US$5.6 billion (£4.5-billion) takeover by Swedish private equity firm EQT and the Abu Dhabi Investment Authority, they announced Friday.

The groups in a statement said they “have reached agreement on the terms and conditions of a recommended cash acquisition”.

The announcement sent Dechra’s share price soaring eight percent to US$45.6 in early deals on London’s rising stock market.

The offer was pitched at US$48.5 per share – a 44-percent premium from April 12 – before Dechra first revealed it was holding bid talks.

Dechra is a “leading company operating in the attractive animal health pharmaceuticals market”, the statement noted.

The sector is “expected to benefit from numerous long-term growth drivers including… increasing pet ownership (and) medical innovation”, it added.

Under the terms of the deal, EQT will own 74 percent of Dechra and the Abu Dhabi sovereign wealth fund the remainder.

The acquisition is expected to complete by early 2024, subject to approvals.

Dechra Pharmaceuticals has more than 2,000 employees and seven production sites across the world, and sells veterinary products in 63 countries.